Gunster attorneys recently helped prepare Sensus Healthcare, a Boca Raton-based manufacturer of equipment to treat nonmelanoma skin cancers and other skin conditions with low-grade radiation, for its initial public offering.
Months of hard work by all involved culminated in Sensus setting its price on June 2 ($5.50 per unit, 2 million units), and began trading on the Nasdaq stock exchange under the ticker symbol SRTSU.
Read related: Attorneys take Boca Raton health care company public (Law.com, 7/19/18) – note: subscription required. Also: Is an IPO right for you? (Gunster.com news, 7/18/16) and Why keeping track of local stocks’ success, or not, is important (PalmBeachPost.com, 9/4/16) note: subscription required.
Sensus Healthcare CEO Joe Sardano rang the opening bell to celebrate the company’s going public.
“Our IPO not only provides us with the capital to expand operations, but also gives us increased visibility among members of the financial community and general public at large,” Sardano said in a June 8 press release.
Gunster’s corporate and securities law team on this IPO included practice leaders David Scileppi and Robert B. Lamm, as well as attorneys Gus Schmidt, Stephanie Quinones and Stacie Townsend.
Sensus Healthcare representatives on the Nasdaq trading floor on June 9, 2016. Note: Gunster attorneys Gus Schmidt and David Scileppi are at far right. Photo courtesy of © 2016 Nasdaq, Inc.
Sensus Healthcare representatives on the Nasdaq trading floor on June 9, 2016. Photo courtesy of © 2016 Nasdaq, Inc.
Sensus Healthcare representatives on the Nasdaq trading floor on June 9, 2016. Photo courtesy of © 2016 Nasdaq, Inc.
Last updated 8/4/16
